{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:03:09Z","timestamp":1789664589243,"version":"4.0.1"},"reference-count":88,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1566,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1111\/j.1399-5448.2011.00782.x","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T04:00:18Z","timestamp":1305864018000},"page":"81-91","source":"Crossref","is-referenced-by-count":42,"title":["The importance of different immunosuppressive regimens in the development of posttransplant diabetes mellitus"],"prefix":"10.1155","volume":"13","author":[{"given":"A","family":"Prokai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Fekete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Pasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Rusai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NF","family":"Banki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Reusz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AJ","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,5,19]]},"reference":[{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996.","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMoa013036","article-title":"Risk of renal allograft loss from recurrent glomerulonephritis.","volume":"347","author":"Briganti","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States.","volume":"3","author":"Kasiske","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diacare.27.2007.S5","article-title":"Diagnosis and classification of diabetes mellitus.","volume":"27","author":"American Diabetes Association.","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.1600-6143.2003.00372.x","article-title":"New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis.","volume":"4","author":"Heisel","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB6|cit6","first-page":"3","article-title":"International Expert Panel. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.","volume":"75","author":"Davidson","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2337\/diacare.25.3.583","article-title":"Post-transplantation diabetes: a systematic review of the literature.","volume":"25","author":"Montori","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.transproceed.2005.12.106","article-title":"Posttransplant diabetes mellitus: impact of good blood glucose regulation on renal transplant recipient outcome.","volume":"38","author":"Sezer","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/TP.0b013e318160ee42","article-title":"Posttransplant diabetes mellitus and acute rejection: impact on kidney transplant outcome.","volume":"85","author":"Matas","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1432-2277.2009.00996.x","article-title":"Impact of glucose metabolism abnormalities on histopathological changes in kidney transplant protocol biopsies.","volume":"23","author":"Helanter\u00e4","year":"2010","journal-title":"Transpl Int"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004670200000","article-title":"Increased incidence in post-transplant diabetes mellitus in children: a case-control analysis.","volume":"17","author":"Greenspan","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/00007890-200109270-00007","article-title":"Post-transplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).","volume":"72","author":"Al-Uzri","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/TP.0b013e3181ae67f0","article-title":"Increasing incidence of new-onset diabetes after transplant among pediatric renal transplant patients.","volume":"88","author":"Burroughs","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB14|cit14","first-page":"2763","article-title":"Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotropic liver transplant patients.","volume":"23","author":"Jain","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1034\/j.1399-0012.2000.140501.x","article-title":"Review of select transplant subpopulations at high risk of failure from standard immunosuppressive therapy.","volume":"14","author":"Deierhoi","year":"2000","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(89)91014-3","article-title":"FK 506 for liver, kidney, and pancreas transplantation.","volume":"2","author":"Starzl","year":"1989","journal-title":"Lancet"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"810.","DOI":"10.1136\/bmj.38569.471007.AE","article-title":"Tacrolimus versus cyclosporine as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomized trial data.","volume":"331","author":"Webster","year":"2005","journal-title":"BMJ"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1097\/00007890-199506000-00018","article-title":"Transcriptional inhibition of insulin by FK506 and possible involvement of FK506 binding protein-12 in pancreatic beta-cell.","volume":"59","author":"Tamura","year":"1995","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1124\/mol.63.6.1289","article-title":"Inhibition of human insulin gene transcription by the immunosuppressive drugs cyclosporine A and tacrolimus in primary, mature islets of transgenic mice.","volume":"63","author":"Oetjen","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1172\/JCI119105","article-title":"Effects of tacrolimus (FK506) on human insulin gene expression, insulin mRNA levels, and insulin secretion in HIT-T15 cells.","volume":"98","author":"Redmon","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1152\/ajpendo.00390.2004","article-title":"Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity.","volume":"288","author":"Radu","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ndt\/gfh1063","article-title":"Evaluating mechanisms of post-transplant diabetes mellitus.","volume":"19","author":"van Hooff","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1681\/ASN.V131221","article-title":"Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction.","volume":"13","author":"Boots","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/j.1432-2277.2005.00191.x","article-title":"Evolution of tacrolimus blood levels and concentration-dose ratios in patients who develop new onset diabetes mellitus after kidney transplantation.","volume":"18","author":"Rodrigo","year":"2005","journal-title":"Transpl Int"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1399-3046.2005.00334.x","article-title":"Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporine micro emulsion.","volume":"9","author":"Filler","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1399-3046.2007.00603.x","article-title":"Post-transplant diabetes mellitus in pediatric liver transplantation.","volume":"13","author":"Hathout","year":"2009","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1034\/j.1600-6143.2003.00186.x","article-title":"Pediatric post-transplant diabetes: data from a large cohort of pediatric heart-transplant recipients.","volume":"3","author":"Hathout","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1399-3046.2007.00862.x","article-title":"Post-transplant diabetes mellitus in children following renal transplantation.","volume":"12","author":"Prokai","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/TP.0b013e3181c47a91","article-title":"Risk factors for development of new-onset diabetes mellitus in pediatric renal transplant recipients: an analysis of the OPTN\/UNOS database.","volume":"89","author":"Kuo","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/ndt\/15.6.867","article-title":"Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients.","volume":"15","author":"Filler","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s004670000476","article-title":"Conversion from tacrolimus to neoral for post-renal transplant diabetes.","volume":"15","author":"Butani","year":"2000","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01973261","article-title":"Biological effects of cyclosporine A: a new antilymphocytic agent.","volume":"6","author":"Borel","year":"1976","journal-title":"Agents Actions"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2337\/diabetes.38.1.58","article-title":"Intravenous glucose tolerance and pancreatic islet beta-cell function in patients with multiple sclerosis during 2-yr treatment with cyclosporine.","volume":"38","author":"Robertson","year":"1989","journal-title":"Diabetes"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00007890-199109000-00022","article-title":"Cyclosporine's effect on insulin secretion in patients with kidney transplants.","volume":"52","author":"Esmatjes","year":"1991","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0303-7207(94)90141-4","article-title":"Inhibitory effects of cyclosporine A on rat insulinoma cell proliferation, polyamine content and insulin secretion.","volume":"99","author":"Sj\u00f6holm","year":"1994","journal-title":"Mol Cell Endocrinol"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"4662.","DOI":"10.1371\/journal.pone.0004662","article-title":"HNF4alpha and HNF1alpha dysfunction as a molecular rational for cyclosporine induced post-transplantation diabetes mellitus.","volume":"4","author":"Borlak","year":"2009","journal-title":"PLoS One"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.2337\/diabetes.34.12.1309","article-title":"Effects of cyclosporine on glucose tolerance in the rat.","volume":"34","author":"Yale","year":"1985","journal-title":"Diabetes"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-0029-1210857","article-title":"Is the cyclosporine A toxicity on rat pancreatic B-cells modulated by the MHC?","volume":"93","author":"Hahn","year":"1989","journal-title":"Exp Clin Endocrinol"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.transproceed.2005.03.137","article-title":"Conversion from tacrolimus to cyclosporine is associated with a significant improvement of glucose metabolism in patients with new-onset diabetes mellitus after renal transplantation.","volume":"37","author":"Bouchta","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.transproceed.2007.06.035","article-title":"Conversion from tacrolimus to cyclosporine could improve control of post-transplant diabetes mellitus after renal transplantation.","volume":"39","author":"Ramos-Cebri\u00e1n","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.transproceed.2004.03.012","article-title":"Post-transplant diabetes mellitus after kidney transplantation with different immunosuppressive agents.","volume":"36","author":"Romagnoli","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/j.1600-6143.2008.02328.x","article-title":"Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late post-transplant period.","volume":"8","author":"Luan","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus.","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1399-3046.2006.00459.x","article-title":"Unexpectedly high prevalence of pre-transplant abnormal glucose tolerance in pediatric kidney transplant recipients.","volume":"10","author":"Shishido","year":"2006","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00007691-199512000-00019","article-title":"Rapamune (Sirolimus, rapamycin): an overview and mechanism of action.","volume":"17","author":"Sehgal","year":"1995","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1007159422667","article-title":"Reciprocal regulation of glycogen phosphorylase and glycogen synthase by insulin involving phosphatidylinositol-3 kinase and protein phosphatase-1 in HepG2 cells.","volume":"211","author":"Syed","year":"2000","journal-title":"Mol Cell Biochem"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1152\/ajpendo.00146.2003","article-title":"Unlike insulin, amino acids stimulate p70S6K but not GSK-3 or glycogen synthase in human skeletal muscle.","volume":"286","author":"Liu","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"33085","DOI":"10.1074\/jbc.274.46.33085","article-title":"Opposite translational control of GLUT1 and GLUT4 glucose transporter mRNAs in response to insulin. Role of mammalian target of rapamycin, protein kinase b, and phosphatidylinositol 3-kinase in GLUT1 mRNA translation.","volume":"274","author":"Taha","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tibs.2004.11.003","article-title":"Restraining PI3K: mTOR signaling goes back to the membrane.","volume":"30","author":"Harrington","year":"2005","journal-title":"Trends Biochem Sci"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1681\/ASN.2005050487","article-title":"Glucose metabolism in renal transplant recipients: effect of calcineurin-inhibitor withdrawal and conversion to sirolimus.","volume":"16","author":"Teutonico","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.tp.0000203894.53714.27","article-title":"A randomized long-term trial of tacrolimus\/sirolimus versus tacrolimus\/mycophenolate versus cyclosporine\/ sirolimus in renal transplantation: three-year analysis.","volume":"81","author":"Ciancio","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00007890-199608150-00002","article-title":"Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model.","volume":"62","author":"Andoh","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.transproceed.2006.03.072","article-title":"Incidence of post-transplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine.","volume":"38","author":"Romagnoli","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.transproceed.2009.01.100","article-title":"Long-term follow-up of 100 high-risk renal transplant recipients converted from calcineurin inhibitors to sirolimus: a single center experience.","volume":"41","author":"Halim","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.transproceed.2006.06.063","article-title":"Conversion to sirolimus in pediatric renal transplantation recipients.","volume":"38","author":"Garcia","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1399-3046.2008.00906.x","article-title":"Tacrolimus withdrawal and conversion to sirolimus at three months post-pediatric renal transplantation.","volume":"12","author":"Hymes","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1399-3046.2005.00324.x","article-title":"Sirolimus in pediatric patients: results in the first 6 months post-renal transplant.","volume":"9","author":"Hymes","year":"2005","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/endo-26-2-309","article-title":"The adrenal cortex and carbohydrate metabolism.","volume":"26","author":"Long","year":"1940","journal-title":"Endocrinology"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000441-197603000-00009","article-title":"Effects of glucocorticoids on carbohydrate metabolism.","volume":"271","author":"Olefsky","year":"1976","journal-title":"Am J Med Sci"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.2337\/diacare.24.12.2121","article-title":"Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy.","volume":"24","author":"Hjelmesaeth","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00007890-199710150-00008","article-title":"Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age.","volume":"64","author":"Hjelmesaeth","year":"1997","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1097\/01.ASN.0000145435.80005.1E","article-title":"Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal.","volume":"15","author":"Midtvedt","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/MNH.0b013e3282f0b319","article-title":"Minimization of immunosuppression in kidney transplantation.","volume":"16","author":"Augustine","year":"2007","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.TP.0000154915.20524.0A","article-title":"CARMEN Study Group. Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation.","volume":"79","author":"Rostaing","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1034\/j.1399-0012.1999.130501.x","article-title":"An alternate mechanism of glucocorticoid anti-proliferative effect: promotion of a Th2 cytokine-secreting profile.","volume":"13","author":"Almawi","year":"1999","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00007890-199002000-00020","article-title":"A prospective randomized trial of prednisone versus no prednisone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients.","volume":"49","author":"Schulak","year":"1990","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-6143.2004.00638.x","article-title":"Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial.","volume":"5","author":"Vanrenterghem","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1681\/ASN.V11101910","article-title":"A meta-analysis of immunosuppression withdrawal trials in renal transplantation.","volume":"11","author":"Kasiske","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1097\/01.TP.0000140969.43761.1F","article-title":"Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials.","volume":"78","author":"Pascual","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0b013e318187d1da","article-title":"A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy.","volume":"248","author":"Woodle","year":"2008","journal-title":"Ann Surg"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/j.1600-6143.2009.02640.x","article-title":"Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits.","volume":"9","author":"Li","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00007890-200101270-00015","article-title":"Post-transplant diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression.","volume":"71","author":"Paolillo","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2165\/00003495-200363240-00009","article-title":"Basiliximab: a review of its use as induction therapy in renal transplantation.","volume":"63","author":"Chapman","year":"2003","journal-title":"Drugs"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1084\/jem.20041982","article-title":"Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization.","volume":"201","author":"Setoguchi","year":"2005","journal-title":"J Exp Med"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.transproceed.2007.06.021","article-title":"Do anti-CD25 monoclonal antibodies potentiate post-transplant diabetes mellitus?","volume":"39","author":"Bay\u00e9s","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1097\/TP.0b013e318188af15","article-title":"Efficacy and safety of Basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids.","volume":"86","author":"Offner","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s004670100642","article-title":"Basiliximab induction improves the outcome of renal transplants in children and adolescents.","volume":"16","author":"Swiatecka-Urban","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1126\/science.2649979","article-title":"The purine path to chemotherapy.","volume":"244","author":"Elion","year":"1989","journal-title":"Science"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10157-007-0467-6","article-title":"Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.","volume":"11","author":"Gheith","year":"2007","journal-title":"Clin Exp Nephrol"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1399-0012.1996.tb00651.x","article-title":"Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).","volume":"10","author":"Allison","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1399-0012.2006.00613.x","article-title":"Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.","volume":"21","author":"Jaber","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/lt.21803","article-title":"Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study.","volume":"15","author":"Karie-Guigues","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1681\/ASN.V123583","article-title":"Influence of tacrolimus on glucose metabolism before and after renal transplantation: a prospective study.","volume":"12","author":"Duijnhoven","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2165\/00002018-200225030-00005","article-title":"Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence.","volume":"25","author":"Jeffcoate","year":"2002","journal-title":"Drug Saf"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1399-543X.2004.00033.x","article-title":"Cystic fibrosis presenting as new onset diabetes mellitus in adolescent twins.","volume":"5","author":"Starkman","year":"2004","journal-title":"Pediatr Diabetes"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"13209","DOI":"10.1073\/pnas.94.24.13209","article-title":"The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism.","volume":"94","author":"Stoffel","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1681\/ASN.V12102175","article-title":"Hepatocyte nuclear factor-1beta: a new kindred with renal cysts and diabetes and gene expression in normal human development.","volume":"12","author":"Kolatsi-Joannou","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1399-5448.2011.00782.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.2337\/diabetes.52.12.2989","article-title":"Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels.","volume":"52","author":"Richter","year":"2003","journal-title":"Diabetes"}],"container-title":["Pediatric Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5448.2011.00782.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1399-5448.2011.00782.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T17:54:32Z","timestamp":1741197272000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5448.2011.00782.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,19]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1399-5448.2011.00782.x","relation":{},"ISSN":["1399-543X"],"issn-type":[{"value":"1399-543X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5,19]]}}}